Sandra J. Taler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sandra J. Taler has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Stephen C. Textor
Mayo Clinic
3 shared publicationsFernando G. Cosio
Division of Nephrology and Hypertension, Mayo Clinic
2 shared publicationsMark D. Stegall
William J Von Liebig Transplant Center, Mayo Clinic, Rochester, MN, USA
2 shared publicationsTimothy S. Larson
Division of Nephrology and Hypertension, Mayo Clinic
2 shared publicationsA. B. Leichtman
Division of Nephrology, University of Michigan, Ann Arbor, MI
1 shared publicationA. J. Matas
Department of Surgery, University of Minnesota, Minneapolis, MN
1 shared publication
Latest Publications
- 1 June 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (6) , ITC81-ITC96
Hypertension
Updated U.S. and international hypertension guidelines reflect new studies and analyses that support changes in hypertension management. The 2025 U.S. guideline for prevention, detection, evaluation, and management of high blood pressure (BP) recommends lower BP targets, greater use of out-of-office BP for diagnosis and medication titration, and a different approach to severe hypertension presenting without acute or evolving cardiovascular disease symptoms or signs. New treatments for resistant hypertension are recommended. Trial evidence supports benefit from tighter BP control to prevent mild cognitive impairment and dementia, further emphasizing the importance of lower BP goals.
- 1 June 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (6) , ITC81-ITC96
Hypertension
Updated U.S. and international hypertension guidelines reflect new studies and analyses that support changes in hypertension management. The 2025 U.S. guideline for prevention, detection, evaluation, and management of high blood pressure (BP) recommends lower BP targets, greater use of out-of-office BP for diagnosis and medication titration, and a different approach to severe hypertension presenting without acute or evolving cardiovascular disease symptoms or signs. New treatments for resistant hypertension are recommended. Trial evidence supports benefit from tighter BP control to prevent mild cognitive impairment and dementia, further emphasizing the importance of lower BP goals.
- 17 February 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (10) , 1814-1825
Obesity in Living Kidney Donors from Risk to Ethics
Obesity is increasingly prevalent among living kidney donor candidates, presenting complex clinical, ethical, and logistical challenges. Although obesity is linked to increased post-donation hypertension, diabetes, proteinuria, and chronic kidney disease, the overall absolute risks are modest and may differ depending on metabolic health and patterns of fat distribution. Current reliance on body mass index alone fails to capture the full spectrum of obesity-related risks, leading to inconsistent donor selection practices and potential inequities. This review examines the pathophysiological mechanisms of obesity-related kidney injury and available evidence on comorbidities and postdonation outcomes related to obesity. We discuss tools for better risk stratification, such as imaging-based adiposity assessment and personalized weight management strategies, and note that some risks may remain after weight loss. Barriers such as rigid body mass index cutoffs, limited access to treatment, and lack of long-term follow-up exacerbate disparities in access to donation. We argue for a shift toward individualized, risk-based evaluation supported by multidisciplinary care. We underscore the importance of donor counseling and advocate for a comprehensive, rather than paternalistic approach to living kidney donor selection. Advancing safe and equitable living donation in the context of rising obesity rates will necessitate revised guidelines, improved access to treatment, and an ongoing commitment to donor well-being.
- 17 February 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (10) , 1814-1825
Obesity in Living Kidney Donors from Risk to Ethics
Obesity is increasingly prevalent among living kidney donor candidates, presenting complex clinical, ethical, and logistical challenges. Although obesity is linked to increased post-donation hypertension, diabetes, proteinuria, and chronic kidney disease, the overall absolute risks are modest and may differ depending on metabolic health and patterns of fat distribution. Current reliance on body mass index alone fails to capture the full spectrum of obesity-related risks, leading to inconsistent donor selection practices and potential inequities. This review examines the pathophysiological mechanisms of obesity-related kidney injury and available evidence on comorbidities and postdonation outcomes related to obesity. We discuss tools for better risk stratification, such as imaging-based adiposity assessment and personalized weight management strategies, and note that some risks may remain after weight loss. Barriers such as rigid body mass index cutoffs, limited access to treatment, and lack of long-term follow-up exacerbate disparities in access to donation. We argue for a shift toward individualized, risk-based evaluation supported by multidisciplinary care. We underscore the importance of donor counseling and advocate for a comprehensive, rather than paternalistic approach to living kidney donor selection. Advancing safe and equitable living donation in the context of rising obesity rates will necessitate revised guidelines, improved access to treatment, and an ongoing commitment to donor well-being.
- 1 March 2023
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 98 (3) , 363-365
Lowering the Norms for Blood Pressure
- 1 March 2023
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 98 (3) , 363-365
Lowering the Norms for Blood Pressure
- 19 February 2022
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 35 (6) , 503-505
The Challenge of Accurate Blood Pressure Measurement: Optimizing Cuff Size and Fit Is Important for All, Not Just for Some
As the world-wide prevalence of obesity continues to rise,1 the importance of screening, diagnosing, and treating hypertension to recommended targets cannot be overstated. Unfortunately, in the setting of obesity, the accurate measurement of blood pressure (BP) is more difficult, primarily related to inadequate cuff size and fit. Most standard BP cuffs currently in use are designed for cylindrical arms and are rectangular in shape. When these cuffs are applied to individuals with obesity, they are often too long on the arm, with the lower cuff border covering the antecubital fossa, and too loose at the distal end of the cuff, leaving substantial space between the skin and the interior of the cuff. This poor cuff fit leads to nonuniform compression of the brachial artery with significant implications for BP measurement accuracy. In addition, the work required to apply larger sized cuffs often requires use of 2 hands, and is generally not feasible for single user application, a particular barrier to self-monitoring of BP.
- 19 February 2022
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 35 (6) , 503-505
The Challenge of Accurate Blood Pressure Measurement: Optimizing Cuff Size and Fit Is Important for All, Not Just for Some
As the world-wide prevalence of obesity continues to rise,1 the importance of screening, diagnosing, and treating hypertension to recommended targets cannot be overstated. Unfortunately, in the setting of obesity, the accurate measurement of blood pressure (BP) is more difficult, primarily related to inadequate cuff size and fit. Most standard BP cuffs currently in use are designed for cylindrical arms and are rectangular in shape. When these cuffs are applied to individuals with obesity, they are often too long on the arm, with the lower cuff border covering the antecubital fossa, and too loose at the distal end of the cuff, leaving substantial space between the skin and the interior of the cuff. This poor cuff fit leads to nonuniform compression of the brachial artery with significant implications for BP measurement accuracy. In addition, the work required to apply larger sized cuffs often requires use of 2 hands, and is generally not feasible for single user application, a particular barrier to self-monitoring of BP.
- Open Access
- 6 August 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (1) , 289-293
Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy
- 6 August 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (1) , 289-293
Open AccessDiffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy
- Open Access
- 1 December 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (5) , 1687-1688
Doctor: Does living kidney donation increase my risk for cardiovascular disease?
- 1 December 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (5) , 1687-1688
Open AccessDoctor: Does living kidney donation increase my risk for cardiovascular disease?
- 1 December 2020
- Published by Wolters Kluwer Health in Hypertension
- Vol. 76 (6) , 1658-1663
Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs
- 1 December 2020
- Published by Wolters Kluwer Health in Hypertension
- Vol. 76 (6) , 1658-1663
Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs
- Open Access
- 1 May 2018
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 71 (5) , 611-614
More From SPRINT (Systolic Blood Pressure Intervention Trial): A Closer Look at the Price of Intensive Blood Pressure Control
- 1 May 2018
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 71 (5) , 611-614
Open AccessMore From SPRINT (Systolic Blood Pressure Intervention Trial): A Closer Look at the Price of Intensive Blood Pressure Control
- 15 February 2018
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 378 (7) , 636-644
Initial Treatment of Hypertension
The 2017 ACC–AHA Hypertension Guideline lowers the blood-pressure treatment target to less than 130/80 mm Hg. Management includes lifestyle modifications and pharmacotherapy, starting with an ACE inhibitor, angiotensin-receptor blocker, calcium-channel blocker, or thiazide diuretic.
- 15 February 2018
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 378 (7) , 636-644
Initial Treatment of Hypertension
The 2017 ACC–AHA Hypertension Guideline lowers the blood-pressure treatment target to less than 130/80 mm Hg. Management includes lifestyle modifications and pharmacotherapy, starting with an ACE inhibitor, angiotensin-receptor blocker, calcium-channel blocker, or thiazide diuretic.